Parkinson's Blog

AbbVie Inc. (NYSE:ABBV) reported second-quarter 2025 sales of $15.42 billion on Thursday, beating the consensus of $14.98 billion. Sales increased 6.6% on a reported basis or 6.5% on an operational basis. The company reported adjusted earnings of $2.97, up 12.1% year over year and missing the consensus of $3.23. Global net revenues from the immunology portfolio were $7.63 billion, up 9.5% (+9.2% on an operational basis), including-Skyrizi sales increased 62.2% (+61.8%) to $4.42 billion; Rinvoq s

A team from WEHI’s Parkinson’s Disease Research Centre has been announced as a finalist for the Eureka Prize for Scientific Research.

A quick, speech-based AI tool offers a new way to screen for a key indicator of Parkinson’s disease.

Rand Laycock has spent his life keeping time, both as a music educator and leader of the Parma Symphony Orchestra. But 11 years ago, him tempo changed when he was diagnosed with Parkinson’s Disease.

The platform assesses cognitive and motor function via at-home assessments that generate digital biomarkers and a predictive score, supporting the early detection of Parkinson’s.

The origin of some neuropsychiatric diseases, such as autism, bipolar disorder, or depression, and certain neurodegenerative diseases, Alzheimer’s and Parkinson’s, can be found in very early stages of brain formation in the fetus. That is, earlier than previously recognized, according to a study by the Hospital del Mar Research Institute and Yale University, published in Nature Communications.

EXCLUSIVE: Paul Sinha fears his health’s a ticking timebomb after a double heart attack and Parkinson’s – and he’s made a chilling prediction about his future.

This looks promising.

A speech-based AI tool developed at the University of Rochester offers a new way to screen for indicators of the neurodegenerative disease.